A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer

Overview of attention for article published in Frontiers in oncology, March 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 22,384 followers.

RT @SawsanRashdanMD: Published! @madbhop @utswcancer

28 Mar 2024

Reply Repost Favourite

Published! @madbhop @utswcancer

28 Mar 2024

Reply Repost Favourite

RT @FrontOncology: New research: A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resect…

28 Mar 2024

Reply Repost Favourite

New research: A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer: Stage IIIA-N2 non-small cell lung cancer (NSCLC) is a heterogeneous group… https://t.

28 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.